ATE243538T1 - Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung - Google Patents

Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung

Info

Publication number
ATE243538T1
ATE243538T1 AT99944936T AT99944936T ATE243538T1 AT E243538 T1 ATE243538 T1 AT E243538T1 AT 99944936 T AT99944936 T AT 99944936T AT 99944936 T AT99944936 T AT 99944936T AT E243538 T1 ATE243538 T1 AT E243538T1
Authority
AT
Austria
Prior art keywords
surface treatment
new method
treatment agents
producing surface
heparin
Prior art date
Application number
AT99944936T
Other languages
English (en)
Inventor
Elisabeth Scholander
Original Assignee
Carmeda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmeda Ab filed Critical Carmeda Ab
Application granted granted Critical
Publication of ATE243538T1 publication Critical patent/ATE243538T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT99944936T 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung ATE243538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances

Publications (1)

Publication Number Publication Date
ATE243538T1 true ATE243538T1 (de) 2003-07-15

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung

Country Status (14)

Country Link
US (1) US6461665B1 (de)
EP (1) EP1112097B1 (de)
JP (1) JP4152075B2 (de)
KR (1) KR100669132B1 (de)
AT (1) ATE243538T1 (de)
AU (1) AU757913B2 (de)
BR (1) BR9913516B1 (de)
CA (1) CA2342991C (de)
DE (1) DE69909104T2 (de)
DK (1) DK1112097T3 (de)
ES (1) ES2203177T3 (de)
NO (1) NO984143L (de)
PT (1) PT1112097E (de)
WO (1) WO2000013718A1 (de)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
JP2002524196A (ja) 1998-09-10 2002-08-06 パーカーディア，インコーポレイティド 左心室血管再生用の経心筋シャントおよびその取付機構
ATE322230T1 (de) 1998-09-10 2006-04-15 Percardia Inc Tmr vorrichtung
US6409697B2 (en) 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US7033372B1 (en) 1999-08-04 2006-04-25 Percardia, Inc. Corkscrew reinforced left ventricle to coronary artery channel
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
US6854467B2 (en) 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6976990B2 (en) 2001-01-25 2005-12-20 Percardia, Inc. Intravascular ventriculocoronary bypass via a septal passageway
US7008397B2 (en) 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
DE60324787D1 (de) * 2002-05-10 2009-01-02 Salviac Ltd System zum filtern von emboli
US7326219B2 (en) 2002-09-09 2008-02-05 Wilk Patent Development Device for placing transmyocardial implant
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
WO2005115490A2 (en) * 2004-05-25 2005-12-08 Surmodics, Inc. Natural biodegradable polysaccharide coatings for meical articles
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
KR101397386B1 (ko) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
CN103071192B (zh) 2006-09-15 2016-04-27 东丽株式会社 基材及其制造方法
US20090281059A1 (en) * 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US20080200421A1 (en) * 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US8114465B2 (en) * 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
US20090018646A1 (en) * 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
WO2010096654A1 (en) 2009-02-21 2010-08-26 Tyco Healthcare Group Lp Medical devices having activated surfaces
EP2398525B1 (de) * 2009-02-21 2012-12-05 Sofradim Production Medizinisches gerät mit abbauverlangsamender beschichtung
US9139669B2 (en) * 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8658707B2 (en) * 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
ES2861359T3 (es) 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
EP2518100B1 (de) 2009-12-24 2015-02-18 Toray Industries, Inc. Hydrophile polymerverbindung mit gerinnungsverhindernder wirkung
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
WO2011147849A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
ES2955183T3 (es) 2011-03-11 2023-11-29 Gore & Ass Mejoras para las entidades biológicas inmovilizadas
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9737398B2 (en) 2012-12-19 2017-08-22 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US10321986B2 (en) 2012-12-19 2019-06-18 W. L. Gore & Associates, Inc. Multi-frame prosthetic heart valve
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
EP3078389B1 (de) 2013-11-28 2020-04-01 Toray Industries, Inc. Antithrombotisches material
WO2015080176A1 (ja) 2013-11-28 2015-06-04 東レ株式会社 抗血栓性材料
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
EP3106128B1 (de) 2014-02-12 2020-12-02 Toray Industries, Inc. Künstliches blutgefäss
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
EP3134146B1 (de) 2014-04-24 2024-12-25 ExThera Medical Corporation Verfahren zur entfernung von bakterien aus blut unter verwendung einer hohen durchflussrate
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
US10857283B2 (en) 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
EP3270825B1 (de) 2015-03-20 2020-04-22 JenaValve Technology, Inc. Herzklappenprothesenzuführsystem
EP3288495B1 (de) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Vorrichtung mit reduzierter herzschrittmacherrate bei herzklappenersatz
EP3095509A1 (de) 2015-05-18 2016-11-23 Defymed Funktionalisierte membrane für biokünstliche organe
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
JP7248430B2 (ja) 2016-04-21 2023-03-29 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 直径を調節可能な内部人工器官ならびに関連したシステムおよび方法
WO2017195125A1 (en) 2016-05-13 2017-11-16 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
ES2957758T3 (es) 2016-09-30 2024-01-25 Toray Industries Copolímero y material médico que contiene el mismo
JP6863295B2 (ja) 2016-10-07 2021-04-21 東レ株式会社 筒状織物
EP3318294A1 (de) 2016-11-08 2018-05-09 Defymed Kit zur in situ-ausgabe einer verbindung von interesse
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
KR20190130618A (ko) 2017-03-31 2019-11-22 도레이 카부시키가이샤 통 형상 구조체
EP3681440A1 (de) 2017-09-12 2020-07-22 W. L. Gore & Associates, Inc. Segelrahmenbefestigung für herzklappenprothesen
EP3687451B1 (de) 2017-09-27 2023-12-13 Edwards Lifesciences Corporation Herzklappenprothese mit erweiterbarem rahmen
JP6875601B2 (ja) 2017-09-27 2021-05-26 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ リーフレットが機械的にカップリングされた人工弁
JP7136901B2 (ja) 2017-10-09 2022-09-13 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 調和されたステントカバー
CA3078699C (en) 2017-10-13 2023-10-10 W.L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
EP3703618A1 (de) 2017-10-31 2020-09-09 W. L. Gore & Associates, Inc. Herzklappenprothese
JP7072062B2 (ja) 2017-10-31 2022-05-19 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 経カテーテル留置システム及び関連する方法
US11439502B2 (en) 2017-10-31 2022-09-13 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
MX2020007446A (es) 2018-01-30 2020-09-14 Toray Industries Tela de tejido liso, metodo de fabricacion de la misma, e injerto de stent.
US20190275212A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Processes for immobilising biological entities
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
CA3105224A1 (en) 2018-07-18 2020-01-23 W. L. Gore & Associates, Inc. Implantable medical device deployment system
CA3110044A1 (en) 2018-10-03 2020-04-09 Carmeda Ab Immobilised biological entities
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
JP7377269B2 (ja) 2018-12-21 2023-11-09 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド インプラント可能な心臓センサ
CN113330151A (zh) 2019-01-30 2021-08-31 东丽株式会社 心血管留置装置用的医疗基材
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
EP3952790A1 (de) 2019-04-12 2022-02-16 W.L. Gore & Associates, Inc. Ventil mit mehrteiligem rahmen und zugehörigen elastischen überbrückungsmerkmalen
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
US20220401105A1 (en) 2019-11-15 2022-12-22 W. L. Gore & Associates, Inc. Left atrial appendage device and methods
EP4090251A1 (de) 2020-01-17 2022-11-23 W. L. Gore & Associates, Inc. Medizinisches implantat mit zwei rahmenkomponenten und ösenpaaren
US20230338727A1 (en) 2020-02-04 2023-10-26 W. L. Gore & Associates, Inc. Inflow / outflow cannula
US20230157588A1 (en) 2020-04-09 2023-05-25 Defymed Membranes for Medical Devices
EP3892259A1 (de) 2020-04-09 2021-10-13 Defymed Membranen für medizinische vorrichtungen
US12171658B2 (en) 2022-11-09 2024-12-24 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) * 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
KR100669132B1 (ko) 2007-01-17
JP2003507082A (ja) 2003-02-25
BR9913516A (pt) 2001-06-05
EP1112097B1 (de) 2003-06-25
DE69909104T2 (de) 2004-04-08
AU757913B2 (en) 2003-03-13
PT1112097E (pt) 2003-11-28
WO2000013718A1 (en) 2000-03-16
CA2342991A1 (en) 2000-03-16
DE69909104D1 (de) 2003-07-31
DK1112097T3 (da) 2003-10-20
EP1112097A1 (de) 2001-07-04
BR9913516B1 (pt) 2010-09-21
CA2342991C (en) 2009-01-27
KR20010088799A (ko) 2001-09-28
NO984143L (no) 2000-03-10
ES2203177T3 (es) 2004-04-01
AU5765299A (en) 2000-03-27
US6461665B1 (en) 2002-10-08
JP4152075B2 (ja) 2008-09-17
NO984143D0 (no) 1998-09-09

Similar Documents

Publication Publication Date Title
ATE243538T1 (de) Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE69900331D1 (de) Verfahren zur Herstellung von Fischgelatine
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE69823361D1 (de) Herstellung von kollagen
DE69840126D1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
DE69504433D1 (de) Verfahren zur Herstellung von korrosionsbeständigen, porösen metallischen Bauteilen
DE3584693D1 (de) Verfahren zur herstellung von kohlenstoffasern des pechtyps.
DE3750714D1 (de) Verfahren zur Behandlung von Kohlenstoffasern mit Urethanen.
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
DE69013826D1 (de) Verfahren zur Herstellung von quaternisiertem Imidazolin, geeignet für die Behandlung von Textilien.
DE3883602D1 (de) Verfahren zur Oberflächenbehandlung von Kohlenstoffasern.
DE69015086D1 (de) Verfahren zur Behandlung von mit Messing beschichtetem Stahldraht.
DE60044504D1 (de) Verfahren zur modifizierung von faserstoff auf cellulosebasis
DE69911644D1 (de) Verfahren zur entwässerung organischer flüssigkeiten
DE69519799D1 (de) Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure
ATE204023T1 (de) Enzymatische verfahren zur herstellung von (s)- cyanhydrinen
DE3781279D1 (de) Verfahren zur behandlung von blut.
UA26438A (uk) СПОСІБ ОТРИМАHHЯ СУЛЬФОHІЛФЕHІЛ- БЕttА-D-ТІОКСИЛОЗИДІВ
ATE382625T1 (de) Verfahren zur herstellung von silanolterminierten oligomeren
DE59000635D1 (de) Verfahren zur herstellung von natriummonosulfid.
ATE82566T1 (de) Verfahren zur herstellung von alpha-(1methylethyl)-3,4-dimethoxybenzeneacetonitril.
ATE241630T1 (de) Verfahren zur herstellung von ucn-01
DE69510798D1 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
DE59910794D1 (de) Verfahren zur Behandlung von Cellulosefasern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112097

Country of ref document: EP